For the Second Straight Year, Over 20 Journal Articles Highlight the Benefits of PBI's Patented PCT Platform in Such Critical Areas of Research as Cancer, Food Safety, and Proteomics https://finance.yahoo.com/news/number-published-scientific-papers-citing-142100983.html
PBIO Pressure BioSciences' Revolutionary UST Platform Featured in Leading North American Cannabis Magazine https://www.otcmarkets.com/stock/PBIO/news/story?e&id=1513494 Cannabis Brightline Article Highlights Potential of PBI's UST Platform to Play Significant Role in Multiple Billion Dollar Markets - Including CBD, Cosmetics, Nutraceuticals, Biopharmaceuticals, and Food/Beverage South Easton, Massachusetts--(Newsfile Corp. - January 17, 2020) - Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced that the Company's new and innovative Ultra Shear Technology™ ("UST™") platform was featured in Cannabis Brightline, one of North America's leading cannabis publications. The article was written and published by Focus Media Group (FMG) of Halifax, NS, Canada. Jason Ellis, President of Vegas CBD Factory, is a recognized expert in the manufacture of cannabinoid-based products. Vegas CBD Factory is located in a 70,000 sq. ft. cGMP and FDA-compliant, state-of-the-art facility in Las Vegas, NV. Mr. Ellis said: "This article highlights a critical issue facing the cannabis market today: the low bioavailability of CBD from CBD-infused products. Because oils (including CBD oil) are not well-absorbed by the water-based systems of humans and other animals, most CBD delivered by ingestion is unfortunately flushed from the body, with very little being absorbed to provide its expected beneficial effects." Mr. Ellis continued: "The article by Cannabis Brightline is very timely, as my colleagues in the cannabis market are now beginning to realize that top quality CBD products will only be generated from using high quality, water-soluble nanoemulsions of CBD oil. I have observed first-hand how existing so-called nanoemulsions of CBD oil flatly fail to deliver effective water-solubility or absorption. Conversely, nanoemulsions created by processing CBD oil through PBI's UST platform provided astonishingly immediate and visually apparent water solubility, which years of science tells us will lead to greatly increased bioavailability. We are now considering the purchase of multiple PBI BaroShear K45 UST nanoemulsion systems in 2020." The Cannabis Brightline article also discussed two other patented and broadly enabling technology platforms developed, owned, and marketed by PBI. In addition, it included a short summary of the important work being supported by PBI's novel pressure-based instruments in such areas as cancer, heart disease, stroke, infectious diseases, and Alzheimer's Disease. The article is available online and can be accessed by clicking on the following link: The Solution for Maximizing the Bioavailability of CBD and Beyond. Richard T. Schumacher, President and CEO of PBI, commented: "It has been very exciting to experience the rapidly growing increase in interest in our UST-based BaroShear K45 nanoemulsification system since the first of the year. In just the past week, we have received nearly a dozen unsolicited phone calls/emails from individuals in North America and Europe. Many callers were aware that our initial build of 12 BaroShear K45 instruments is expected to begin in early 2020, and they wanted to ensure they could secure a spot on the initial build purchase list." Mr. Schumacher continued: "Because of strong and growing interest, we remain comfortable with our earlier guidance that BaroShear K45 revenue in 2020 will greatly exceed current revenue from our PCT and BaroFold platforms combined. We look forward with anticipation to the initial release of the BaroShear K45 nanoemulsification system, currently planned for September 2020."
PBIO New Order for Six BaroShear K45 Systems Brings Total to Nine Orders Received for Company's New Ultra Shear Technology™ Based Platform. Additional Orders Expected Shortly Would Sell Out Planned Initial Build of 12 Systems, with Approximate Total Value of $2.4 Million. https://www.otcmarkets.com/stock/PB...y-Nanoemulsification-System-for-Wat?id=252148
PBIO Introduction of New Benchtop, R&D Scale, UST-Based "BaroShear Mini" in Q3 2020 Expected to Speed Market Penetration of PBI's UST Platform for Processing CBD and Other Oils into Stable, High Quality, Water-Soluble Nanoemulsions New Instrument for Product Formulation and Development to Address Many Large and Diverse Markets https://www.otcmarkets.com/stock/PB...le-CBD-with-Planned-Release-of-Addi?id=252638
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences industry, today announced that Zacks Small Cap Research ("Zacks SCR") has released an updated research report in its on-going coverage on the Company. Copies of the new Zacks SCR report can be obtained via the following link: https://s1.q4cdn.com/460208960/files/News/2020/Zacks_SCR_Research_02052020_PBIO_Senko.pdf Any opinions, judgments, estimates, or forecasts regarding the Company's historical or predicted performance or operations made by Zacks SCR are theirs alone and do not represent opinions, judgments, estimates, or forecasts of the Company or its management. The Company does not by its reference to the research prepared by Zacks SCR imply its endorsement or adoption of or concurrence with such information, conclusions, or recommendations.
PBIO News! Pressure BioSciences Nearing Complete Sellout on Pre-launch Offering of Game-Changing UST System ... https://finance.yahoo.com/news/pressure-biosciences-nearing-complete-sellout-121600026.html?soc_src=hl-viewer&soc_trk=tw via @YahooFinance
$PBIO 4/16 News! Pressure BioSciences and RedShiftBio Demonstrate Potential of Combining Proprietary Technologies to Enable New Tool for Development and Production of Biotherapeutics https://finance.yahoo.com/news/pres...l-150300072.html?soc_src=social-sh&soc_trk=tw
PBIO Pressure BioSciences Announces Plans to Acquire Cannaworx, Inc. https://finance.yahoo.com/news/pressure-biosciences-announces-plans-acquire-121500615.html?soc_src=social-sh&soc_trk=tw via @YahooFinance
PBIO Pressure BioSciences Announces Planned Name Change to "Availa Bio" Following Completion of Cannaworx and SkinScience Labs Transactions https://finance.yahoo.com/news/pressure-biosciences-announces-planned-name-121500402.html
PBIO Pressure BioSciences Announces Launch of FDA-Registered Hand Sanitizer as First Product Developed Through Pending Merger Partners https://finance.yahoo.com/news/pressure-biosciences-announces-launch-fda-121500204.html
PBIO $3,500,000 Initial Order for FDA-Registered, Premium Hand Sanitizer Catapults SkinScience Labs, a... https://finance.yahoo.com/news/3-500-000-initial-order-121600035.html?soc_src=social-sh&soc_trk=tw via @YahooFinance
PBIO Pressure BioSciences and Leica Microsystems Sign Worldwide Co-Marketing Alliance: The Power of La... https://finance.yahoo.com/news/pressure-biosciences-leica-microsystems-sign-121000498.html?soc_src=social-sh&soc_trk=tw via @YahooFinance
PBIO Pressure BioSciences Achieves Critical Milestone in Revolutionary Nanoemulsification Technology Development; Enters Production Era for Commercial System Development https://finance.yahoo.com/news/pres...tical-milestone-121000394.html?.tsrc=fin-srch
PBIO Pressure BioSciences, Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update. Instrument Sales Increase 68%, Total Revenue Increases 7%, Operating Loss Decreases 23% (Q/Q); Planned Release of Revolutionary UST System in Mid-2021 Expected to Drive Major Revenue Growth and Progression to Profitability https://finance.yahoo.com/news/pressure-biosciences-inc-reports-third-152600390.html
PBIO Pressure BioSciences to Present at Upcoming Life Sciences Investor Forum https://finance.yahoo.com/news/pres...t-upcoming-life-145400437.html?.tsrc=fin-srch
PBIO Life Sciences Company Investor Presentations Now Available for On-Demand Viewing https://www.lifesciencesinvestorfor...medium=Press Release&utm_campaign=Dec2020LSIF
PBIO Pressure BioSciences Ultra Shear Technology Nanoemulsions Platform Targets Revolution in Effectiveness of Therapeutics via Improved Drug Delivery and Dosing Safety https://finance.yahoo.com/news/pres...hear-technology-133100494.html?.tsrc=fin-srch